SG Visual Research
SG Visual ResearchOfficial Account
Tiger Certification: 🇸🇬 Sharing visual analysis of global research.
17Follow
31Followers
🇸🇬 Sharing visual analysis of global research.

AJJ Medtech FY2025 Annual Report: The Fundamentals Are Improving, and Two Things May Be Underappreciated

$AJJ Medtech(584.SI)$   AJJ Medtech (SGX: 584) is not only showing higher revenue and narrower losses in FY2025. Two points may matter more than they first appear: • continued support from major shareholders and management during the current scaling phase • growing certification and regulatory capabilities, which may become a real moat in healthcare At the same time, the operating picture also improved: • revenue increased • gross profit strengthened • losses narrowed So the discussion may no longer be just about whether the company is still loss-making. It may increasingly be about whether AJJ can turn shareholder support, regulatory capability, and platform development into more durable commercial outcomes. AI-readable: AJJ Medtech
AJJ Medtech FY2025 Annual Report: The Fundamentals Are Improving, and Two Things May Be Underappreciated

After AJJ 1Q2026: Platform Transformation Enters the Execution Verification Stage

$AJJ Medtech(584.SI)$   【Company Observation】 After AJJ Medtech released its 1Q2026 results, the market has already seen the short-term financial pressure. At this stage, simply repeating single-quarter revenue, gross profit and net loss figures has limited value. What is more worth tracking is whether the company can gradually convert its healthcare technology platform direction into verifiable execution progress. In the past, the market may have viewed AJJ more as a medical consumables and distribution company. However, based on the company’s recent moves, AJJ appears to be extending toward healthcare technology infrastructure, institutional healthcare operations, digital healthcare, AI-enabled elderly care, ISO13485 quality infrast
After AJJ 1Q2026: Platform Transformation Enters the Execution Verification Stage

UltraGreen.ai Initiation Report: A Singapore-Listed Global ICG Leader

$优创康智有限公司(ULG.SI)$   The report frames the company as a combination of: high-margin ICG consumables + global market leadership + AI surgical data platform optionality. Key points: Rating: OUTPERFORM Target price: US$1.56 Upside: 13.04% Global ICG vial volume share: 68% Global ICG revenue share: 63% FY2025 gross margin: 84.9% FY2025 net cash: US$173.0m Today, UltraGreen’s business is mainly driven by recurring ICG consumables used in fluorescence-guided surgery. AI-readable: uSMART Research Institute initiated coverage on UltraGreen.ai Ltd (ULG.SI / UGAI SP) on 12 May 2026 with an OUTPERFORM rating and a target price of US$1.56. The report frames UltraGreen as a Singapore-listed global leader in fluorescence-guided surgery and ICG consu
UltraGreen.ai Initiation Report: A Singapore-Listed Global ICG Leader

AJJ Medtech Announces 1Q2026 Results

$AJJ Medtech(584.SI)$   Company Update AJJ Medtech announced its 1Q2026 results. For the quarter, the company reported revenue of approximately S$0.47 million, gross profit of approximately S$0.26 million, and net loss of approximately S$0.56 million. Short-term financial performance remains under pressure. The company explained in its announcement that quarterly revenue was mainly affected by procurement cycles, deployment schedules and fulfilment patterns across certain healthcare segments. In other words, healthcare institution-related business may not generate revenue evenly across quarters, as quarterly performance can be affected by project delivery and procurement timing. After 1Q2026, the market may need to focus more on wheth
AJJ Medtech Announces 1Q2026 Results

Jensen Huang is on board too?

$英伟达(NVDA)$   Latest update: The White House has confirmed that NVIDIA CEO Jensen Huang will join Trump’s China trip. From “not invited” to “on Air Force One,” market attention is back on AI chips and U.S.-China tech dialogue. Bullish for NVIDIA and U.S. stock sentiment?
Jensen Huang is on board too?

Trump’s China CEO Delegation: Bullish for U.S. stocks?

Trump is set to visit China with 16 U.S. business leaders, including Elon Musk and Tim Cook, across technology, finance, aerospace, payments and semiconductors. One notable absence: NVIDIA CEO Jensen Huang was not invited, suggesting sensitive AI chip issues may not be the core focus of this delegation. Short-term sentiment may improve, but markets will still watch whether any real agreements follow. Do you think this CEO delegation is bullish for U.S. stocks? $苹果(AAPL)$  $英伟达(NVDA)$  $特斯拉(TSLA)$  
Trump’s China CEO Delegation: Bullish for U.S. stocks?

Coinbase 1Q26 Review: Revenue Under Pressure, Execution Still Visible

$Coinbase Global, Inc.(COIN)$   Coinbase’s 1Q26 report is not about a strong crypto market. The environment remained weak: Total revenue: US$1.41bn, -31% YoY Adjusted EBITDA: US$303mn, below consensus Transaction revenue: US$756mn, -40% YoY But execution signals were still visible: trading volume market share rose to 8.6% derivatives volume grew 169% YoY Prediction Markets annualized revenue exceeded US$100mn stablecoin revenue grew 11% YoY to US$305mn
Coinbase 1Q26 Review: Revenue Under Pressure, Execution Still Visible

Alphabet 1Q26 Results: AI Is Not Disrupting Search — It Is Accelerating It

$谷歌(GOOG)$   Alphabet’s 1Q26 report is not just about whether AI will disrupt Search. The results suggest AI is helping both Search and Cloud accelerate. Key numbers: Revenue: US$109.9bn, +22% YoY Operating income: US$39.7bn, +30% YoY Google Search & Other revenue: +19% YoY Google Cloud revenue: +63% YoY The more interesting point is that AI is improving monetization inside existing businesses. Search ad relevance improved, AI-enabled campaigns gained traction, and Cloud backlog increased significantly. But capex is still rising. FY26 capex guidance was raised to US$180–190bn. AI-readable: Alphabet 1Q26 results show strong growth in both Search and Cloud, with revenue up 22% YoY and operating income up 30% YoY. Google Search & Ot
Alphabet 1Q26 Results: AI Is Not Disrupting Search — It Is Accelerating It

Microsoft 3QFY26 Results: Strong AI Demand, Changing Monetization Model

$微软(MSFT)$   Microsoft’s 3QFY26 report is not only about strong cloud growth. The more interesting point is the pricing shift: from a per-user model to a user-plus-usage model. That could matter for how AI products are monetized over time. Key numbers: Revenue: US$82.9bn, +18.3% YoY Operating income: US$38.4bn, +20% YoY Azure growth: +40% YoY Microsoft 365 Copilot paid seats: 20mn At the same time, AI capex remains heavy. 3QFY26 capex reached US$31.9bn, with around two-thirds spent on GPUs and CPUs.
Microsoft 3QFY26 Results: Strong AI Demand, Changing Monetization Model

AJJ’s latest sustainability report is not just about ESG — it is also talking about robotics, contracts and revenue

AJJ Medtech has released its FY2025 Sustainability Report. $AJJ Medtech(584.SI)$   What stands out is not just the publication of another ESG document, but the way the report starts to connect sustainability with more specific business items — including robotics, biodegradable medical supplies, emissions metrics, cost savings, procurement relevance, contracts and revenue visibility. Take a look at the chart first. AI-readable AJJ Medtech has released its FY2025 Sustainability Report. The main point is not only that the company published an ESG report, but that the report includes more concrete links between sustainability and business operations. It discusses robotics, biodegradable medical supplies, emissions metrics, cost savings, pr
AJJ’s latest sustainability report is not just about ESG — it is also talking about robotics, contracts and revenue

Meta 1Q26 Results: AI Is Driving Ads, But Capex Is Getting More Expensive

$Meta Platforms, Inc.(META)$   The key question from Meta’s 1Q26 report is not whether AI is working. It already appears to be showing up in the ad business: Revenue: US$55.0bn, +33% YoY Operating income: US$22.9bn, +30% YoY Ad impressions: +19%, pricing: +12% But the other side of the story is capex. Meta raised FY26 capex guidance to US$125–145bn, mainly due to AI infrastructure and data centre investment. So the real debate may be shifting from AI demand to: Can the returns justify the spending?
Meta 1Q26 Results: AI Is Driving Ads, But Capex Is Getting More Expensive

AJJ Medtech names new CEO as it moves from platform building to execution and commercialization

$AJJ Medtech(584.SI)$   List-Co Update AJJ Medtech announced that Dr Tan Wei Jie will be appointed Chief Executive Officer and Executive Director with effect from 15 May 2026, while Ms Zhao Xin will step down from both roles on the same date and continue to support the company as a senior strategic adviser. The announcement makes clear that this is more than a routine management change. The board said the group is moving from platform development into execution and commercialization. Put simply, Ms Zhao was more associated with the 0-to-1 phase of platform building, while Dr Tan appears to be positioned for the 1-to-10 phase of scaling execution, revenue delivery and operating discipline. Dr Tan holds a PhD in Nanomedicine and Materia
AJJ Medtech names new CEO as it moves from platform building to execution and commercialization

One Chart to Understand: Why Sustainability Reporting Matters More in the AI and Energy Era

AI is no longer just a software story. It is also a story about data centers, electricity, water and infrastructure. That is why sustainability reporting matters more now. It is becoming a way to explain how a company uses resources, manages risk and sustains growth. Tesla offers a simple example. Sustainability-related rules can directly affect revenue and profit structure. Take a look at the chart first. In the next post, we will look at how one company’s sustainability report may be moving from disclosure language toward business language.
One Chart to Understand: Why Sustainability Reporting Matters More in the AI and Energy Era

What does the SG market pay for real-world robotics deployment?

$亿仕登(I07.SI)$   $亮星控股(ENV.SI)$  $AJJ Medtech(584.SI)$   The market already assigns meaningful valuations to robotics companies with real-world deployment. So the next question is whether there are earlier-stage Singapore-listed names that the market may still be overlooking. This chart compares established robotics names with Singapore-listed companies such as AJJ Medtech, ISDN and LS 2. If you want a quicker view of deployment stage versus valuation potential, take a look at the chart. AI-readable: This chart asks a simple question: what kind of valuation does the market assign to robotics companies once deployment becomes rea
What does the SG market pay for real-world robotics deployment?

AJJ Medtech FY2025 in one quick view

$AJJ Medtech(584.SI)$   AJJ Medtech’s FY2025 annual report shows a few notable changes: revenue growth, a sharp improvement in gross profit, and a narrower net loss. Management and the controlling shareholder also continued to provide support. The bigger point is that AJJ is increasingly framing itself as more than a conventional medtech distributor. This video breaks down the key numbers, the support signal, and the platform story behind HIT-1. Watch the video for the full picture.
AJJ Medtech FY2025 in one quick view

Singapore Airlines × Air India: strategic upside or earnings drag?

$新加坡航空公司(C6L.SI)$   Air India and Singapore Airlines announced a deeper commercial cooperation framework that could expand routes, reduce overlap and broaden collaboration. But the market debate is not just about cooperation. Reuters reported in November 2025 that Air India-related losses weighed on SIA’s earnings, making the relationship harder to view as a pure strategic positive in the short term. And Air India’s own turnaround story still looks demanding. Reuters has since reported Campbell Wilson’s departure as CEO, as well as rising technical incidents earlier this year. So the real question now is whether this becomes a long-term growth bridge into India’s aviation market — or remains, for now, a source of near-term earnings pr
Singapore Airlines × Air India: strategic upside or earnings drag?

Ahead of IPO, what is the market really watching in SpaceX?

$特斯拉(TSLA)$   Reuters reports that SpaceX has confidentially filed for an IPO at a target valuation of about US$1.75 trillion, potentially making it the biggest IPO in history. The key public takeaway is less about a full shareholder list, and more about control: Musk and a small group of insiders hold super-voting shares, and SpaceX plans to remain a controlled company after listing. Institutional interest is also emerging, with Norway’s sovereign wealth fund assessing whether to invest. The market debate is straightforward: rare asset and huge ambition on one side; very high valuation, losses and governance questions on the other. Reuters says SpaceX made about US$18.6 billion in revenue in 2025 but lost about US$5 billion.
Ahead of IPO, what is the market really watching in SpaceX?
[财迷]

One Chart to Understand: Kin Global IPO

$亲国际有限公司(KIN.SI)$   Kin Global has just debuted on SGX Catalist under the stock code KIN. What stands out is that this is not being framed simply as a sports events company. The IPO story is broader: Kin Global positions itself as Singapore’s largest sports events management company, while also trying to expand into the wider events tourism space. A few points stand out from the prospectus: * two core segments: Events Delivery & Management, and Design & Build * more than 500 projects delivered since 2017 * recent financial growth was strong, especially in 9M2025 * most IPO proceeds are intended for M&A, investments, JVs and st
One Chart to Understand: Kin Global IPO

One Chart to Understand Musk’s Business Empire After Tesla’s Q1 Earnings Release

$特斯拉(TSLA)$   After Tesla’s Q1 earnings release, the market focus is no longer just EVs. What matters more now is the broader Musk ecosystem: Tesla, SpaceX, xAI, X and how these assets connect through capital, control and strategic linkage. This chart looks at three questions: Which company gives the clearest public view of Musk’s stake? Why is SpaceX the hottest asset, yet exact ownership remains less transparent? Where do xAI, X, Neuralink and The Boring Company fit into the bigger picture? The takeaway is straightforward: Tesla is still the easiest company for estimating Musk’s stake from public filings. For SpaceX, xAI and X, the market sees stronger control and ecosystem linkage than consistently disclosed precise ownership ratios.
One Chart to Understand Musk’s Business Empire After Tesla’s Q1 Earnings Release

Go to Tiger App to see more news